Details of the Drug Formulations

General Information of Drug (ID: DMWE2N4)

Drug Name

Auranofin Drug Info

Synonyms

Ridaura; Ridauran; Ridaura (TN); SK&F 39162; SK&F-39162; Gold, (1-thio-.beta.-D-glucopyranosato)(triethylphosphine)-, 2,3,4,6-tetraacetate; (1-Thio-.beta.-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate

Indication

Disease Entry	ICD 11	Status	REF
Inflammatory arthritis	FA2Z	Approved	[1]

Therapeutic Class

Antirheumatic Agents

Cross-matching ID

PubChem CID: 24199313
CAS Number: 34031-32-8
TTD ID: D0L2UN
VARIDT ID: DR01329
ACDINA ID: D00051

Full List of Drug Formulations Containing This Drug

Auranofin 3 mg capsule

Company	Formulation ID	FDA Description
Prometheus Laboratories; Sebela Pharmaceuticals	F02101	Lactose; Sodium lauryl sulfate; Fd&c red no. 40; Benzyl alcohol; D&c red no. 33; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Cetylpyridinium chloride; Titanium dioxide; Povidone; Cellulose, microcrystalline; Gelatin; Sodium starch glycolate type a potato; Starch, corn
------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6306).